Extensive studies reported genetically engineered MSCs with tumour necrosis factor-related apoptosis-inducing ligand TRAIL, BMP4, and PTEN efficiently suppressed glioma tumour growth and induced apoptosis [[48], [49], [50]]. The gene discussed is TNFSF10; the disease is central nervous system cancer.